
Privacy notice | Accessibility statement | Terms and conditions | Login | Contact |
UK data driving real-world evidence
Bibliography
Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,700 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 4 March 2021) and papers are listed below and in the PDF below.
If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.
Download:
(PDF, 3MB, 220 pages)This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website.
Export 150 results:
Author Title Type [ Year
Filters: First Letter Of Title is S [Clear All Filters]
“Safety of antidepressants in a primary care cohort of adults with obesity and depression”, PLoS One, vol. 16, p. e0245722, 2021.
, “Sex, Age, and Socioeconomic Differences in Nonfatal Stroke Incidence and Subsequent Major Adverse Outcomes”, Stroke, vol. 52, pp. 396-405, 2021.
, “SGLT-2 inhibitors and the risk of hospitalization for community-acquired pneumonia: A population-based cohort study”, Pharmacoepidemiol Drug Saf, 2021.
, “Shorter and longer courses of antibiotics for common infections and the association with reductions of infection-related complications including hospital admissions”, Clin Infect Dis, 2021.
, “Statins After Ischemic Stroke in the Oldest: A Cohort Study Using the Clinical Practice Research Datalink Database”, Stroke, p. Strokeaha120030755, 2021.
, “A study of cancer occurrence in users of mirabegron and antimuscarinic treatments for overactive bladder”, Curr Med Res Opin, p. 1, 2021.
, “Safety of inadvertent administration of live zoster vaccine to immunosuppressed individuals in a UK-based observational cohort analysis”, BMJ Open, vol. 10, p. e034886, 2020.
, “Safety of oral bisphosphonates in moderate-to-severe chronic kidney disease: a bi-national cohort analysis”, J Bone Miner Res, 2020.
, “Seasonal influenza vaccination during pregnancy and the risk of major congenital malformations in live-born infants: A 2010-2016 historical cohort study”, Clin Infect Dis, 2020.
, “Sepsis recording in primary care electronic health records, linked hospital episodes and mortality records: Population-based cohort study in England”, PLoS One, vol. 15, p. e0244764, 2020.
, “Serious bacterial infections and antibiotic prescribing in primary care: cohort study using electronic health records in the UK”, BMJ Open, vol. 10, p. e036975, 2020.
, “Severe hypoglycaemia and absolute risk of cause-specific mortality in individuals with type 2 diabetes: a UK primary care observational study”, Diabetologia, 2020.
, “Similar risk of cardiovascular events in idiopathic inflammatory myopathy and rheumatoid arthritis in the first 5 years after diagnosis”, Clin Rheumatol, 2020.
, “Statin use and risk of joint replacement due to osteoarthritis and rheumatoid arthritis: a propensity-score matched longitudinal cohort study”, Rheumatology (Oxford), 2020.
, “Statins, bone biology and revision arthroplasty: review of clinical and experimental evidence”, Ther Adv Musculoskelet Dis, vol. 12, p. 1759720x20966229, 2020.
, “Stoma formation in Crohn's Disease and the likelihood of antidepressant use: a population-based cohort study”, Clin Gastroenterol Hepatol, 2020.
, , “Selectivity of beta-blockers, cardiovascular and all-cause mortality in people with hypoglycaemia: An observational study”, Nutr Metab Cardiovasc Dis, vol. 29, pp. 481-488, 2019.
, “Serum potassium and clinical outcomes in heart failure patients: results of risk calculations in 21 334 patients in the UK”, ESC Heart Fail, 2019.
, “Socioeconomic deprivation and regional variation in Hodgkin's lymphoma incidence in the UK: a population-based cohort study of 10 million individuals”, BMJ Open, vol. 9, p. e029228, 2019.
, “Socioeconomic disadvantage and the risk of advanced chronic kidney disease: results from a cohort study with 1.4 million participants”, Nephrology Dialysis Transplantation, 2019.
, “Socio-economic inequalities in life expectancy of older adults with and without multimorbidity: a record linkage study of 1.1 million people in England”, Int J Epidemiol, 2019.
, “Sodium-Glucose Cotransporter 2 Inhibitors and the Risk of Fractures Among Patients With Type 2 Diabetes”, Diabetes Care, vol. 42, pp. e150-e152, 2019.
, “Statins After Myocardial Infarction in the Oldest: A Cohort Study in the Clinical Practice Research Datalink Database”, J Am Geriatr Soc, 2019.
, “Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Association with Commonly Prescribed Drugs in Outpatient Care Other than Anti-Epileptic Drugs and Antibiotics: A Population-Based Case-Control Study”, Drug Saf, vol. 42, pp. 55-66, 2019.
, “Study Design and Cohort Comparability in a Study of Major Cardiovascular Events in New Users of Prucalopride Versus Polyethylene Glycol 3350”, Drug Saf, 2019.
, “A study on the epidemiology of tinnitus in the United Kingdom”, Clin Epidemiol, vol. 11, pp. 855-871, 2019.
, , , , “Safety of multicomponent meningococcal group B vaccine (4CMenB) in routine infant immunisation in the UK: a prospective surveillance study”, Lancet Child Adolesc Health, vol. 2, pp. 395-403, 2018.
, “Searching for a prodrome for rheumatoid arthritis in the primary care record: A case-control study in the clinical practice research datalink”, Semin Arthritis Rheum, 2018.
, “Selection of men for investigation of possible testicular cancer in primary care: a large case-control study using electronic patient records”, Br J Gen Pract, vol. 68, pp. e559-e565, 2018.
, “Selective serotonin reuptake inhibitor use and breast cancer survival: a population-based cohort study”, Breast Cancer Res, vol. 20, p. 4, 2018.
, “Self-harm in a primary care cohort of older people: incidence, clinical management, and risk of suicide and other causes of death”, Lancet Psychiatry, vol. 5, pp. 905-912, 2018.
, “Serum potassium as a predictor of adverse clinical outcomes in patients with chronic kidney disease: new risk equations using the UK clinical practice research datalink”, BMC Nephrol, vol. 19, p. 211, 2018.
, “Severe and predominantly active atopic eczema in adulthood and long term risk of cardiovascular disease: population based cohort study”, Bmj, vol. 361, p. k1786, 2018.
, “Severe mental illness and chronic kidney disease: a cross-sectional study in the United Kingdom”, Clin Epidemiol, vol. 10, pp. 421-429, 2018.
, “Sex and BMI Alter the Benefits and Risks of Sulfonylureas and Thiazolidinediones in Type 2 Diabetes: A Framework for Evaluating Stratification Using Routine Clinical and Individual Trial Data”, Diabetes Care, vol. 41, pp. 1844-1853, 2018.
, “SGLT-2 Inhibitors and Cardiovascular Risk: An Analysis of CVD-REAL”, J Am Coll Cardiol, vol. 71, pp. 2497-2506, 2018.
, “Short- and long-term cost and utilization of health care resources in Parkinson's disease in the UK”, Mov Disord, vol. 33, pp. 974-981, 2018.
, “Smoking Status at Diagnosis and Subsequent Smoking Cessation: Associations With Corticosteroid Use and Intestinal Resection in Crohn's Disease”, Am J Gastroenterol, vol. 113, pp. 1689-1700, 2018.
, “Spatial distribution of clinical computer systems in primary care in England in 2016 and implications for primary care electronic medical record databases: a cross-sectional population study”, BMJ Open, vol. 8, p. e020738, 2018.
, “Statin use and reduced risk of biliary tract cancers in the UK Clinical Practice Research Datalink”, Gut, 2018.
, “Statin use and survival in patients with gastric cancer in two independent population-based cohorts”, Pharmacoepidemiol Drug Saf, 2018.
, “Statin use in cancer survivors versus the general population: cohort study using primary care data from the UK clinical practice research datalink”, BMC Cancer, vol. 18, p. 1018, 2018.
, “Study investigating the generalisability of a COPD trial based in primary care (Salford Lung Study) and the presence of a Hawthorne effect”, BMJ Open Respir Res, vol. 5, p. e000339, 2018.
, “Sulfonylureas as Initial Treatment for Type 2 Diabetes and the Risk of Severe Hypoglycemia”, Am J Med, vol. 131, pp. 317.e11-317.e22, 2018.
, “Sulfonylureas as second line drugs in type 2 diabetes and the risk of cardiovascular and hypoglycaemic events: population based cohort study”, Bmj, vol. 362, p. k2693, 2018.
, “Supplementing electronic health records through sample collection and patient diaries: A study set within a primary care research database”, Pharmacoepidemiol Drug Saf, vol. 27, pp. 239-242, 2018.
,